Log In
Print
BCIQ
Print
Print this Print this
 

Decuprate (WTX101) (formerly ATN-224)

  Manage Alerts
Collapse Summary General Information
Company Wilson Therapeutics AB
DescriptionSecond generation analog of ammonium tetrathiomolybdate
Molecular Target Superoxide dismutase (SOD1) mRNA
Mechanism of ActionSuperoxide dismutase (SOD1) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationWilson's disease
Indication DetailsTreat Wilson's disease
Regulatory Designation

U.S. - Orphan Drug (Treat Wilson's disease);
EU - Orphan Drug (Treat Wilson's disease)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today